Castle Biosciences (CSTL) Q2 2026 Earnings

6MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.9
-0.55
-0.2
0.15

Details

Expected EPS
-0.49
Actual EPS
-0.49
Surprise EPS
0
Surprise Percent
+0%

Description

Castle Biosciences (CSTL) has reported earnings of -0.49 per share for Q2 2026.

0 Comments

Share your thoughts